BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35583405)

  • 41. Cutaneous involvement with marginal zone lymphoma.
    Gerami P; Wickless SC; Querfeld C; Rosen ST; Kuzel TM; Guitart J
    J Am Acad Dermatol; 2010 Jul; 63(1):142-5. PubMed ID: 20462658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Follicular lymphoma and marginal zone lymphoma: how many diseases?
    Laurent C; Cook JR; Yoshino T; Quintanilla-Martinez L; Jaffe ES
    Virchows Arch; 2023 Jan; 482(1):149-162. PubMed ID: 36394631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Splenic marginal zone B-cell lymphoma with epidermotropic skin involvement].
    Gómez-de la Fuente E; Villalón LB; Calzado-Villarreal L; Pinedo-Moraleda F; López-Estebaranz JL
    Actas Dermosifiliogr; 2012 Jun; 103(5):427-31. PubMed ID: 21885023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA profiling of low-grade and transformed nodal marginal zone lymphoma reveals a similar signature pattern distinct from diffuse large B cell lymphoma.
    Gebauer N; Thorns C; Bernard V; Senft A; Schillert A; Merz H; Feller AC; Bernd HW
    Acta Haematol; 2015; 133(2):214-20. PubMed ID: 25376122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Marginal zone B-cell lymphoma affecting the skin: histological and phenotypic study of 49 cases].
    Bathelier E; Thomas L; Balme B; Coiffier B; Berger F; Ffrench M; Salles G; Dalle S
    Ann Dermatol Venereol; 2008 Nov; 135(11):748-52. PubMed ID: 19061653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases.
    Grønbaek K; Møller PH; Nedergaard T; Thomsen K; Baadsgaard O; Hou-Jensen K; Zeuthen J; Guldberg P; Ralfkiaer E
    Br J Dermatol; 2000 May; 142(5):913-23. PubMed ID: 10809848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin.
    Kheterpal MK; Dai J; Geller S; Pulitzer M; Ni A; Myskowski PL; Moskowitz A; Kim J; Hong EK; Fong S; Hoppe RT; Kim YH; Horwitz SM
    J Am Acad Dermatol; 2019 Oct; 81(4):970-976. PubMed ID: 30703460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
    Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS.
    Hüttl KS; Staiger AM; Richter J; Ott MM; Kalmbach S; Klapper W; Biesdorf AS; Trümper L; Rosenwald A; Ziepert M; Horn H; Ott G
    Virchows Arch; 2021 Sep; 479(3):575-583. PubMed ID: 33655392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD30 expression in cutaneous B-cell lymphomas.
    Afolayan-Oloye O; Zhao L; Tejasvi T; Chan MP; Harms PW; Fullen DR; Wilcox RA; Hristov AC
    J Cutan Pathol; 2023 Sep; 50(9):819-827. PubMed ID: 37290910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization.
    Yang B; Tubbs RR; Finn W; Carlson A; Pettay J; Hsi ED
    Am J Surg Pathol; 2000 May; 24(5):694-702. PubMed ID: 10800988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.
    Maeshima AM; Taniguchi H; Toyoda K; Yamauchi N; Makita S; Fukuhara S; Munakata W; Maruyama D; Kobayashi Y; Tobinai K
    Br J Haematol; 2016 Sep; 174(6):923-31. PubMed ID: 27460179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma.
    Huang S; Nong L; Wang W; Liang L; Zheng Y; Liu J; Li D; Li X; Zhang B; Li T
    Diagn Pathol; 2019 Jul; 14(1):81. PubMed ID: 31315646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Marginal zone B-cell lymphomas.
    Sagaert X; Tousseyn T
    Discov Med; 2010 Jul; 10(50):79-86. PubMed ID: 20670602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
    Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
    Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL).
    Park JH; Kim S; Ryu JS; Lee SW; Park CS; Huh J; Suh C
    Hematol Oncol; 2018 Feb; 36(1):56-61. PubMed ID: 28401574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual.
    Wang E; Papalas J; Hutchinson CB; Kulbacki E; Huang Q; Sebastian S; Rehder C; Silbermins D; Moore J; Datto M
    Am J Surg Pathol; 2011 Mar; 35(3):457-63. PubMed ID: 21317718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.
    Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV
    Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome.
    Tibiletti MG; Martin V; Bernasconi B; Del Curto B; Pecciarini L; Uccella S; Pruneri G; Ponzoni M; Mazzucchelli L; Martinelli G; Ferreri AJ; Pinotti G; Assanelli A; Scandurra M; Doglioni C; Zucca E; Capella C; Bertoni F
    Hum Pathol; 2009 May; 40(5):645-52. PubMed ID: 19144384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.